We rely on the FDA to protect public health “by assuring the safety, efficacy, and security” of medical drugs and devices. The takes its marching orders from Congress via the legislative process. One such law is the Compounding Quality Act of 2013, passed in response to a series of fatal infections due to improper compounding pharmacy processes. While such oversight is important and well meaning, the unintended consequences may be profound.
In my medical specialty of retina surgery, compounded and off-label save Medicare $3 billion per year. Studies have shown the lower cost is equivalent to the much more expensive in treating macular degeneration. Many physicians will try Avastin as the first line of treatment in their patients and continue using it if it is working well.
is used in the treatment of macular degeneration, diabetic retinopathy, and other retinal conditions. At a cost of 40 times less than the approved options, using compounded instead of the on-label expensive alternatives could Read more: http://dailycaller.com/2014/07/11/new-regulations-force-doctors-to-choose-between-expensive-medicine-and-more-visits/#ixzz37B2aOgEe
No comments:
Post a Comment